Control of plasma glucose with alpha-glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice.
about
Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic ratsData Mining as a Powerful Tool for Creating Novel Drugs in Cardiovascular Medicine: The Importance of a "Back-and-Forth Loop" Between Clinical Data and Basic Research.The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma.Differential roles of nitric oxide synthase isozymes in cardiotoxicity and mortality following chronic doxorubicin treatment in mice.Influence of glycemic control on gain in VO2 peak, in patients with type 2 diabetes enrolled in cardiac rehabilitation after an acute coronary syndrome. The prospective DARE studyThe inhibitory activity of herbal medicines on the keys enzymes and steps related to carbohydrate and lipid digestion.Effect of Berberine on PPAR α /NO Activation in High Glucose- and Insulin-Induced Cardiomyocyte Hypertrophy.Acute hyperglycemia suppresses left ventricular diastolic function and inhibits autophagic flux in mice under prohypertrophic stimulationHistone Deacetylase Inhibitor Phenylbutyrate Exaggerates Heart Failure in Pressure Overloaded Mice independently of HDAC inhibition.The impact of current and novel anti-diabetic therapies on cardiovascular risk.Personalized cardiovascular medicine: concepts and methodological considerations.Lipid effects and cardiovascular disease risk associated with glucose-lowering medications.Effects of Epinephrine on Inflammation-Related Gene Expressions in Cultured Rat Cardiomyocytes.Dipeptidyl-peptidase IV inhibition improves pathophysiology of heart failure and increases survival rate in pressure-overloaded mice.Dystrophin-deficiency increases the susceptibility to doxorubicin-induced cardiotoxicity.
P2860
Q28572349-A9FC4455-245F-46E4-8941-DBBD5A959DD9Q30975654-B32B2BA4-CA9B-4813-9E34-F63E9B2B1185Q34174680-9110D7E3-781A-4C59-8CE6-E3E53AD5FAD8Q34902125-BC0ECA0D-E3B0-437A-B73A-D67094AC45E4Q35685463-3DE05452-0FC0-4D52-A0C1-F86D8B7D8CE7Q36183233-AB9BDFDF-E837-4854-92EE-07C3876BE9E6Q36739688-AD8CCB4A-ED9F-4B8E-A910-4B198D64A296Q37278532-29ED9E81-34BA-439A-95DE-75F914F67AAEQ37281996-0BAEC462-CFA4-4E25-B98A-0A873021ED86Q38062033-EC725D71-135D-40EC-91A5-B5A42A4CAF69Q38093034-64E18D1E-B239-4016-AFDB-52E105C3DA2FQ38511039-CF23CF4A-7538-4338-88E4-E5BEF0A434A3Q42321345-32DD777D-08C3-471E-BBED-6E3FCAB82216Q44319013-8BD93853-4180-414B-8699-32DD892B103FQ46987056-39179248-5766-4316-B0DD-A620AEF9E526
P2860
Control of plasma glucose with alpha-glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Control of plasma glucose with ...... sion of heart failure in mice.
@en
Control of plasma glucose with ...... sion of heart failure in mice.
@nl
type
label
Control of plasma glucose with ...... sion of heart failure in mice.
@en
Control of plasma glucose with ...... sion of heart failure in mice.
@nl
prefLabel
Control of plasma glucose with ...... sion of heart failure in mice.
@en
Control of plasma glucose with ...... sion of heart failure in mice.
@nl
P2093
P1476
Control of plasma glucose with ...... sion of heart failure in mice.
@en
P2093
Jiyoong Kim
Masafumi Kitakaze
Masashi Fujita
Masatsugu Hori
Seiji Takashima
Tetsuo Minamino
Yasunori Shintani
Yoshihiro Asano
Yulin Liao
P304
P356
10.1016/J.CARDIORES.2006.01.021
P577
2006-02-28T00:00:00Z